| |
|
|
|
Applied Dna Scns  
|
|
7.7593 -0.171 (-0.02%) |
10-21 14:30 |
|
Open: |
7.98 |
Pre close: |
7.93 |
Target:
|
9.74
|
|
High: |
7.98 |
Low: |
7.6756 |
Resistance:
|
8.34
8.94
|
|
Volume: |
28,791 |
Market Cap: |
42M |
Support:
|
7.37
6.13
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.76
 |
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
7.77 |
Signal(12,26,9): |
-0.11  |
|
MA(100): |
8.41 |
Stochastic Oscillator |
%K(14,3):
|
32.80 |
|
MA(250): |
6.62 |
%D(3): |
27.74 |
|
Average Volume(K) |
3-Month: |
61544
|
52-Week |
High:
|
19.69 |
|
10-Days: |
12836 |
Low: |
2.52 |
|
RSI |
RSI(14):
|
46.97 |
Change(%): |
-16.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.600 |
Return on Equity (ttm) |
-290.0 |
Shares Out. (M) |
5.14 |
|
EPS Est. Current Year |
-0.440 |
Return on Assets (ttm) |
-76.3 |
Shares Float (M) |
4.44 |
|
EPS Est. Next Year |
-0.230 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.45 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-79.0 |
% Held by Institutions |
19.80 |
|
Forward EPS |
-9.690 |
Gross Profit (p.s.) |
0.877 |
Shares Short (K) |
450 |
|
Book Value (p.s.) |
1.770 |
EBITDA (p.s.) |
-1.959 |
P/E |
-2.14 |
|
Sales Per Share |
0.640 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.94 |
P/S |
12.06 |
|
Operating Margin |
-314.44 |
Levered Free Cash Flow
(M) |
-5.33 |
P/CF |
-3.99 |
|
|
|
|
|
|
